Position in MRNA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,756,912
+$453,334 QoQ
Shares Held
25,088
-2.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#231
of 772 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. MRNA ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,614 | $45,507,422 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,220 | $17,596,298 | |
| 3 | INCY |
Incyte Corp
|
104,901 | $11,891,577 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,327 | $8,828,306 | |
| 5 | RPRX |
Royalty Pharma plc
|
136,283 | $7,641,386 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,736 | $3,321,598 | |
| 7 | INSM |
INSMED Inc
|
27,552 | $2,937,594 | |
| 8 | MRNA |
Moderna, Inc.
This page
|
25,088 | $1,756,912 |
All Filings in MRNA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,756,912 | 25,088 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,303,578 | 25,661 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $545,889 | 18,511 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $556,842 | 21,558 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $442,405 | 16,035 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $724,795 | 25,566 | Shares | Sole | 2025-12-02 | |
| 2024-12-31 | $879,457 | 21,151 | Shares | Defined | 2025-12-09 | |
| 2024-09-30 | $1,033,324 | 15,462 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $2,176,925 | 18,332 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $1,444,207 | 13,553 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $5,142,857 | 51,713 | Shares | Defined | 2025-12-09 | |
| 2023-09-30 | $3,055,937 | 29,586 | Shares | Defined | 2025-12-09 | |
| 2023-06-30 | $4,654,300 | 38,307 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $6,612,540 | 43,056 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $5,657,670 | 31,498 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $4,318,017 | 36,516 | Shares | Sole | 2025-12-09 | |
| 2022-06-30 | $5,301,162 | 37,110 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $7,851,610 | 45,580 | Shares | Sole | 2025-12-09 | |
| 2021-12-31 | $14,372,473 | 56,589 | Shares | Defined | 2025-12-29 | |
| 2021-09-30 | $18,205,032 | 47,303 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $3,282,200 | 13,968 | Shares | Sole | 2025-12-29 | |
| 2021-03-31 | $1,078,635 | 8,237 | Shares | Sole | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||